PND3 Risk-Benefit Analysis of Therapy in Multiple Sclerosis
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.469
https://www.valueinhealthjournal.com/article/S1098-3015(11)02031-6/fulltext
Section Title :
Neurological Disorders
Section Order :
441
First Page :
A317
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02031-6&doi=10.1016/j.jval.2011.08.469